An older GLP-1 medication, sold as Saxenda for weight management and Victoza for diabetes, taken as a daily (rather than weekly) injection. It generally produces less weight loss than the newer weekly drugs semaglutide and tirzepatide, and the daily dosing is less convenient. It still has a role, and a lower-cost generic version has become available, unlike the newer agents.
Related terms: Saxenda · Semaglutide · Tirzepatide · Generic drug